News Room

  • August 25, 2017
    Altasciences Clinical Research Offers Innovative Cannabis Research Solutions
    Altasciences is pleased to share that they are in the final stages of completing the world’s first safety and tolerability study on a cannabis extract being developed as a new chemical entity for approval by the FDA and Health Canada as a drug.
  • August 8, 2017
    Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders in the Life Sciences Industry
    Altasciences Clinical Research, one of the largest early phase Clinical Research Organizations (CROs) in North America, is pleased to announce that Chris Perkin, Chief Executive Officer, has been named one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine for a third consecutive year — an honor bestowed on individuals recognized for the positive impact they have had on the industry through their leadership, influence and positive actions.
  • March 15, 2017
    Altasciences Clinical Research Companies Recognized for Leadership
    Altasciences Clinical Research proudly announces that its companies, Algorithme Pharma and Vince & Associates Clinical Research, have each been awarded multiple 2017 CRO Leadership Awards.
  • January 11, 2017
    Vince & Associates Clinical Research, an Altasciences Company, Opens Vaping Room
    OVERLAND PARK, KS (January 11, 2017) – Vince & Associates Clinical Research, an Altasciences company, announced today the opening of a controlled ventilation indoor vaping room at their clinical research unit in Overland Park, Kansas.
  • December 5, 2016
    Altasciences Clinical Research Wins Best CRO Scrip Award
    Altasciences was selected from among many leading CROs by an expert Judging Panel, comprised of independent, senior industry experts from around the world, each chosen for their knowledge, objectivity and credibility.